source
- Stage IV Breast Cancer Cases Rise Over Past Decade, Dana-Farber Study ShowsA recent analysis by Dana-Farber Cancer Institute examined breast cancer diagnoses over the past ten years. The researchers found that the number of patients diagnosed with stage IV disease has ri…
- Experts anticipate Daraxonrasib and new GI cancer therapies at ASCO 2026Ahead of the 2026 ASCO Annual Meeting, leading oncologists and researchers focusing on gastrointestinal cancers highlighted the topics they expect to dominate the conference. Central among the buz…